Drug Profile
Coronavirus vaccine - ImmunoPrecise Antibodies
Alternative Names: SARS-CoV-2 Vaccine - ImmunoPrecise AntibodiesLatest Information Update: 28 Mar 2024
Price :
$50
*
At a glance
- Originator ImmunoPrecise Antibodies
- Class COVID-19 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical COVID 2019 infections
Most Recent Events
- 28 Mar 2024 No recent reports of development identified for research development in COVID-2019-infections in USA (Injection)
- 14 Dec 2020 Immunogenicity and adverse event data from a preclinical studies in COVID-2019 infections released by ImmunoPrecise antibodies and LiteVax
- 25 Sep 2020 Preclinical trials in COVID-2019 infections (Prevention) in USA (Injection)